Clinical Neurology and Neurosurgery is devoted to publishing papers and reports on the clinical aspects of neurology and neurosurgery. It is an international forum for papers of high scientific standard that are of interest to Neurologists and Neurosurgeons world-wide.Professor Peter Paul De Deyn, Scientific Director of the Institute Born-Bunge at the University of Antwerp, Belgium, is the Editor-in-Chief. The journal has a broad international perspective.Types of Papers:• Reviews• Neurological progress, concerning new developments in the field of clinical neurology and neurosurgery• Special articles, written by invited authors• Original articles, full-length papers devoted to the scope and purpose of the journal• Case histories, reporting unusual clinical syndromes or diseases. These papers should be no less than 3 pages print, not including illustrations and tables• Letters to the Editor, comments on articles in Clinical Neurology and Neurosurgery• Book reviews• Announcements are carried at the Editor's and Publisher's discretion.
Research fields covered by Geologica Saxonica are geology, paleontology, stratigraphy, petrography, mineralogy and geoscience history with focus on Central Europe.
The journal of the Museum of Mineralogy and Geology was founded in 1876 by Hanns Bruno Geinitz as „Mitteilungen aus dem Königlichen Mineralogisch-Geologischen und Prähistorischen Museum“. It was refounded in 1955 by Hans Prescher as „Jahrbuch des Staatlichen Museums für Mineralogie und Geologie zu Dresden“ and continued from 1966 as „Abhandlungen des Staatlichen Museums für Mineralogie und Geologie zu Dresden“. Since 2001 the periodical is entitled „Geologica Saxonica – Journal of Central European Geology“.
Melba (The Journal of Machine Learning for Biomedical Imaging) is a web-based journal devoted to the free and unrestricted access of high quality articles in the broad field that bridges machine learning and biomedical imaging. Melba’s aims include:
Molecular & Cellular Toxicology (MCT) is owned and published by the Korean Society of Toxicogenomics and Toxicoproteomics. It is published four times a year in a printed version. Its editorial policies are the responsibility of the editor, the associated editors, and the editorial board under the general authority of the publications committee and the council.
Neurophysiology is an international scientific journal. It features a broad, interdisciplinary scope, which covers studies on molecular, cellular, and systemic neurophysiology, functional neuromorphology, neuropharmacology, and neurochemistry. Papers on neuromuscular physiology, neural mechanisms of higher nervous activity and behavior, neurophysiology, medical aspects of neurophysiology, and modeling of neural functions are also accepted. Both original experimental papers and review papers on contemporary problems of neuroscience can be submitted.
The journal Nutrition presents advances in nutrition research and science, informs its readers on new and advancing technologies and new data in clinical nutrition practice, encourages the application of the techniques of outcomes research and meta-analyses to problems in patient-related nutrition; and seeks to help clarify and set the research, policy and practice agenda for nutrition science to enhance human well-being in the years ahead.Nutrition is the associate journal of three international nutrition societies. For more details, see Society Information.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Physical Review Letters (PRL) is the premier APS journal for current research, providing rapid publication of short reports of important fundamental research in all fields of physics. PRL provides its diverse readership with weekly coverage of major advances in physics and cross-disciplinary developments.
Trends in Anaesthesia and Critical Care aims to be a leading biomedical review journal, providing reviews and comment on highly topical subjects and the latest breakthroughs in basic, clinical and translational research. This includes basic and clinical research aimed at understanding disease processes and clinical practice of importance to anaesthesia and critical care. The aim is to stimulate debate on new research, cover controversial topics, or provide a new framework for, or interpretation of, an old problem or current issue, or speculate on the implications of recent research and clinical advances in health care infrastructure concerns at national or international levels. Many of these subjects also raise ethical, legal and financial issues and TACC may include articles on such matters.The journal's objective is to provide a platform for discussion, analysis and debate of these topics across a diverse, multidisciplinary audience of basic scientists and clinicians, who share the common goal of understanding anaesthesiology, pain, pharmacology, critical care and related subject areas with a view to new clinical practice. Communication of the emerging concepts and ideas will facilitate progress in exciting and evolving field of anaesthesia and critical care.Reviews and Opinion articles form the foundation of each bimonthly issue. Reviews objectively chronicle recent and important developments. Opinion articles provide a forum for debate and hypothesis. The Focus section includes short articles highlighting topical issues and providing comment on recent research papers of particular note. Articles are carefully commissioned, peer-reviewed and edited to provide authoritative, critical and accessible insights.Trends in Anaesthesia and Critical Care also welcomes correspondence. Letters may address topics raised in recent issues of the journal, or other matters of general interest to the field. The decision to publish rests with the Editor-in-Chief at all times. The author(s) of articles discussed in a Letter will normally be invited to reply.If you are interested in suggesting an article for consideration, please submit a one-page summary with a list of key references. Authors should note that all articles are peer reviewed and publication cannot be guaranteed.
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:1) Transfusion - Transmitted Disease and its Prevention:*Identification and epidemiology of infectious agents transmissible by blood;*Bacterial contamination of blood components;* Donor recruitment and selection methods;* Pathogen inactivation.2) Blood Component Collection and Production:*Blood collection methods and devices (including apheresis);*Plasma fractionation techniques and plasma derivatives;* Preparation of labile blood components;* Inventory management;*Hematopoietic progenitor cell collection and storage;* Collection and storage of tissues;* Quality management and good manufacturing practice;* Automation and information technology.3) Transfusion Medicine and New Therapies:*Transfusion thresholds and audits;* Haemovigilance;* Clinical trials regarding appropriate haemotherapy;** Non-infectious adverse affects of transfusion;* Therapeutic apheresis;* Support of transplant patients;* Gene therapy and immunotherapy.4) Immunohaematology and Immunogenetics:* Autoimmunity in haematology;* Alloimmunity of blood;* Pre-transfusion testing;* Immunodiagnostics;* Immunobiology;* Complement in immunohaematology;* Blood typing reagents;* Genetic markers of blood cells and serum proteins: polymorphisms and function;* Genetic markers and disease;* Parentage testing and forensic immunohaematology.5) Cellular Therapy:* Cell-based therapies;Stem cell sources;** Stem cell processing and storage;* Stem cell products;* Stem cell plasticity;* Regenerative medicine with cells;* Cellular immunotherapy;* Molecular therapy;* Gene therapy.